Log in
CVE:MBI

Med Biogene Stock Forecast, Price & News

C$0.04
-0.01 (-18.18 %)
(As of 10/3/2019)
Add
Compare
Today's Range
C$0.05
Now: C$0.05
C$0.05
50-Day Range
C$0.05
MA: C$0.04
C$0.05
52-Week Range
C$0.02
Now: C$0.05
C$0.08
Volume2,000 shs
Average Volume29,135 shs
Market CapitalizationC$596,610.00
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Med BioGene Inc., a life science company, focuses on the development and commercialization of genomic-based clinical laboratory diagnostic tests for cancer. Its products include the GeneFx Lung, a gene expression-based test for early-stage non-small-cell lung cancer that assists in identifying patients for adjuvant chemotherapy. The company has a collaboration agreement with the University Health Network in Toronto. Med BioGene Inc. was founded in 2002 and is headquartered in Vancouver, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-604-7327332
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Cash FlowC$0.01 per share
Book ValueC$0.00 per share

Profitability

Miscellaneous

Market CapC$596,610.00
Next Earnings Date5/5/2021 (Estimated)
OptionableOptionable
C$0.04
-0.01 (-18.18 %)
(As of 10/3/2019)
30 days | 90 days | 365 days | Advanced Chart

Receive MBI News and Ratings via Email

Sign-up to receive the latest news and ratings for MBI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Med Biogene (CVE:MBI) Frequently Asked Questions

What stocks does MarketBeat like better than Med Biogene?

Wall Street analysts have given Med Biogene a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Med Biogene wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Med Biogene's next earnings date?

Med Biogene is scheduled to release its next quarterly earnings announcement on Wednesday, May 5th 2021.
View our earnings forecast for Med Biogene
.

Who are some of Med Biogene's key competitors?

Who are Med Biogene's key executives?

Med Biogene's management team includes the following people:
  • Dr. Iain Weir-Jones Ph.D., P.Eng., FGS, Chairman & CEO
  • Mr. Ibrahim Ghobrial, Chief Financial Officer

What is Med Biogene's stock symbol?

Med Biogene trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MBI."

How do I buy shares of Med Biogene?

Shares of MBI and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Med Biogene's stock price today?

One share of MBI stock can currently be purchased for approximately C$0.05.

How big of a company is Med Biogene?

Med Biogene has a market capitalization of C$596,610.00.

What is Med Biogene's official website?

The official website for Med Biogene is www.medbiogene.com.

How can I contact Med Biogene?

Med Biogene's mailing address is 598 E Kent Ave South, VANCOUVER, BC V5X 4V6, Canada. The company can be reached via phone at +1-604-7327332.

This page was last updated on 11/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.